Positron Emission Mammography and Standard Mammography in Women at High Risk of Breast Cancer

Completed · Not applicable

Conditions studied: Breast Cancer

In brief

RATIONALE: Screening tests may help doctors find cancer cells early and plan better treatment for breast cancer. It is not yet known whether positron emission mammography is more effective than standard mammography in finding breast tumors. PURPOSE: This phase III trial is studying positron emission mammography to see how well it works compared with standard mammography in women undergoing screening mammogram at Boston Medical Center.

Key facts

Study ID

NCT00896649

Run by

Boston Medical Center

People needed

193

Starts

2009-02-01

Expected to finish

2017-01-01

Last updated by the study team

2017-05-09

Who can join

Age: 35 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• DISEASE CHARACTERISTICS:
• Scheduled to undergo screening mammogram at one of the Boston Medical Center-affiliated primary care clinics and meets 1 of the following criteria:
• Dense breast tissue
• At high-risk for breast cancer
• PATIENT CHARACTERISTICS:
• Has 1 of the following racial or ethnic backgrounds based on the patient's country of birth or the mother and father's country of birth:
• Hispanic
• Haitian Creole
• African American
• Caucasian
• PRIOR CONCURRENT THERAPY:
• None specified

You may not qualify if…

• No history of breast cancer, palpable breast mass, abnormal nipple discharge, or other focal complaints warranting diagnostic mammogram

Where it is running

• Boston University Cancer Research Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.